Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00230867 · ClinicalTrials.gov registry record · Phase 2
Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis
A Phase 2 study of Herpes Labialis, sponsored by Transport Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,800
- Enrollment target
- 20
- Study locations
NCT00230867: Completed Phase 2 study of Herpes Labialis, sponsored by Transport Pharmaceuticals.
NCT00230867 is a Phase 2 study of Herpes Labialis that has completed, run by Transport Pharmaceuticals. The registered enrollment target is 1,800 participants, above the 763-participant average among 6 other Herpes Labialis trials with a reported enrollment target (136% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00230867, a Phase 2 study of Herpes Labialis, has completed, sponsored by Transport Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,800 participants
- Enrollment target
- 20
- Study locations
Study Summary
Currently approved drugs for the treatment of herpes labialis (cold sores) exhibit low levels of efficacy due to the limited ability of the drugs to penetrate the skin to the site where the herpes virus is replicating. Iontophoresis uses electric current to enhance the delivery of drugs through the skin. This trial is testing a new iontophoretic device for the delivery of acyclovir cream to treat cold sores.
Conditions Studied
Interventions
- DEVICE iontophoretic acyclovir
Study Locations (20)
Arizona
- Radiant Research Phoenix Southeast - Chandler
- Radiant Research Phoenix - Phoenix
- Radiant Research Scottsdale - Scottsdale
Florida
- Radiant Research St. Petersburg - Pinellas Park
- Radiant Research Stuart - Stuart
- Radiant Research West Palm - West Palm Beach
California
- Radiant Research San Diego - San Diego
- Radiant Research Santa Rosa - Santa Rosa
Georgia
- Radiant Research Atlanta West - Atlanta
- Radiant Research Atlanta - Atlanta
Ohio
- Radiant Research Cincinnati - Cincinnati
- Pediatric Clinical Trials International - Columbus
Alabama
- Radiant Research Birmingham - Birmingham
Idaho
- Radiant Research Boise - Boise
Illinois
- Radiant Research Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,800 participants |
| Start Date | 2005-04 |
| Est. Completion | 2005-12 |
| Phase | Phase 2 |
What the finished NCT00230867 record still lists
NCT00230867 is an interventional study that assigns participants to a tested intervention. Its 1,800 participants enrollment target places it among the larger protocols in the corpus, above the 763-participant average among 6 other Herpes Labialis trials with a reported enrollment target (136% higher).
The record links to 1 condition, with Herpes Labialis appearing as the primary indexed condition, and to 1 intervention - of which iontophoretic acyclovir is the first listed.
NCT00230867 names 20 study sites across 13 states, led by Arizona, Florida, California.
Frequently Asked Questions
What is clinical trial NCT00230867 about?
NCT00230867 is a clinical study titled "Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis". Currently approved drugs for the treatment of herpes labialis (cold sores) exhibit low levels of efficacy due to the limited ability of the drugs to penetrate the skin to the site where the herpes virus is replicating. Iontophoresis uses electric current to enhance the delivery of drugs through the ...
What is the current status of trial NCT00230867?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,800 participants. The study started on 2005-04. Estimated completion is 2005-12.
What conditions does trial NCT00230867 study?
This clinical trial studies the following conditions: Herpes Labialis.
What interventions are being tested in trial NCT00230867?
The interventions under investigation include: iontophoretic acyclovir (DEVICE).
Who is sponsoring clinical trial NCT00230867?
This trial is sponsored by Transport Pharmaceuticals, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00230867 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Herpes Labialis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis
COMPLETED · Phase 2
-
Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
COMPLETED · Phase 2
-
Viral Infections in Healthy and Immunocompromised Hosts
RECRUITING
-
Phase 3 Clinical Study for the Treatment of Cold Sore
COMPLETED · Phase 3
-
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
COMPLETED · Phase 3
-
Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
- NCT05258656 · 1,800 participants · NA
Childhood Activities Nutrition and Development Oversight
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia